Secondary prognosis after cardioembolic stroke of atrial origin: The role of left atrial and left atrial appendage dysfunction

Clinical Cardiology

Volumn 26, Issue 6, 2003, Pages 269-274

  Panagiotopoulos, Konstantinos ^a,b   Toumanidis, Savvas ^a   Vemmos, Konstantinos ^a   Saridakis, Nikolaos ^a   Stamatelopoulos, Stamatis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Atrial fibrillation; Cardioembolic stroke; Left atrial appendage; Prognosis; Sinus rhythm

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RECURRENT DISEASE; SINUS RHYTHM; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0037532759     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4950260606     Document Type: Article

References (11)

1. Cerebral Embolism Task Force: Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743
2. Sherman DG, Hart RG, Easton DJ: The secondary prevention of stroke in patients with atrial fibrillation. Arch Neurol 1986;43:68-70
3. Kamp O, Verhorst PMJ, Welling RC, Visser CA: Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 1999;20:979-985
4. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP: Relationship of cardiac disease to stroke occurrence, recurrence and mortality. Stroke 1992;23:1250-1256
5. Panagiotopoulos K, Toumanidis S, Saridakis N, Vemmos K, Moulopoulos S: Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation. J Am Soc Echocardiogr 1998;11:711-719
6. Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL, for the Stroke Prevention in Atrial Fibrillation Investigators: Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (the Stroke Prevention in Atrial Fibrillation [SPAF-III] Study). J Am Soc Echocardiogr 1999;12:1080-1087
7. Feinberg WM, Blackshear JL, Laupacis A, Krommal R, Hart RG: Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med 1995;155:469-473
8. Van Latum JC, Koudstaal PJ, Venables GS, van Gijn J, Kappelle LJ. Algra A: Predictors of major vascular events in patients with a transient ischaemic attack or minor ischaemic stroke and with nonrheumatic atrial fibrillation. Stroke 1995;26:801-806
9. European Atrial Fibrillation Trial Study Group: Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262
10. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomised controlled trials. Arch Intern Med 1994;154:1449-1457
11. Flegel KM, Hanley J: Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 1989;20:1000-1004